CoChat

Thyroxine promotes lung cancer growth in an orthotopic mouse model

Open access

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Abstract

Thyroid hormones are important for physiology and homeostasis. In addition to nuclear thyroid hormone receptors, the plasma membrane protein integrin α v β 3 has been recognized as a receptor for both thyroxine (T 4 ) and triiodothyronine (T 3 ). Here, we studied whether thyroid hormone promotes growth of murine lung cancer via α v β 3 in vivo . Murine Lewis lung carcinoma cells (3LL), stably transfected with luciferase, were injected into mouse lungs. Tumor growth in untreated mice was compared to hypothyroid mice and hypothyroid mice treated with T 3 or T 4 with or without the α v β 3 inhibitor 3,5,3′,5′-tetraiodothyroacetic acid (Tetrac). Tumor progression was determined by serial in vivo imaging of bioluminescence emitted from the tumor. Tumor weight was recorded at the end of the experiment. Neoangiogenesis was determined by immunohistochemistry for CD31. Tumor growth was reduced in hypothyroidism and increased by T 4 treatment. Strikingly, only T 4 but not T 3 treatment promoted tumor growth. This T 4 effect was abrogated by the α v β 3 inhibitor Tetrac. Tumor weight and neoangiogenesis were also significantly increased only in T 4 -treated mice. The T 4 effect on tumor weight and neoangiogenesis was abolished by Tetrac. In vitro , T4 did not stimulate 3LL cell proliferation or signaling pathway activation. We conclude that T 4 promotes lung cancer growth in this orthotopic mouse model. The tumor-promoting effect is mediated via the plasma membrane integrin α v β 3 and increased neoangiogenesis rather than direct stimulation of 3LL cells. These data suggest that such effects of levothyroxine may need to be considered in cancer patients on T 4 substitution.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1530/erc-18-0353

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. 2003, Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF, Cell Stress & Chaperones, 8, 37, 10.1379/1466-1268(2003)8 · doi:10.1379/1466-1268(2003)8

Cited by

See all 31

Metadata

Authors
Latteyer, S., Christoph, S., Theurer, S., Hönes, G. S., Schmid, K. W., Führer, D., & Moeller, L. C.
Affiliations
University of Duisburg-Essen (DE)
Corresponding author
Moeller, L C
Venue
Endocrine-Related Cancer
Published
2019-06
Volume
26
Issue
6
Pages
565-574
ISSN
  • 1351-0088 (ISSN-L)
  • 1479-6821
OpenAlex
W2922920959
Cited by
31
References
32
Citations by year
2026: 1 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 11 · 2020: 7 · 2019: 2
FWCI
4.22
Type
journal article
Language
en
Open access
Locations
  • Endocrine Related Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
Funders
  • University of Chicago
  • Deutsche Forschungsgemeinschaft
  • Universität Duisburg-Essen
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
thyroxine, lung cancer, integrin αvβ3, thyroid hormones, tumor growth, neoangiogenesis, Lewis lung carcinoma, hypothyroidism, triiodothyronine, tetraiodothyroacetic acid, levothyroxine, thyroid hormone receptor
MeSH terms
Animals, Hypothyroidism, Male, Mice, Inbred C57BL, Neovascularization, Pathologic, Thyroxine, Tumor Cells, Cultured, Apoptosis, Carcinoma, Lewis Lung, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.